tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

West Pharmaceutical ups FY23 adjusted EPS view to $7.65-$7.80 from $7.50-$7.65

Consensus $2.98B. Raises FY23 revenue view to $2.97B-$3B from $2.97B-$2.99B. Sees FY23 capital spending $350M.

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

See today’s best-performing stocks on TipRanks >>

Read More on WST:

Disclaimer & DisclosureReport an Issue

1